A biotechnology company focused on developing antibody-drug conjugate (ADC) therapies for cancer. Its lead products and pipeline target ovarian and other solid tumors by combining tumor‑targeting antibodies with potent cell‑killing agents. Investors track the firm for clinical trial results, regulat...
This page tracks all publicly disclosed congressional trades in ImmunoGen, Inc. (IMGN), a company in the Healthcare sector. 1 member of Congress has disclosed trades in this stock, including 1 purchase and 1 sale. All data is sourced from STOCK Act Periodic Transaction Reports filed with the House and Senate disclosure offices.
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2017-01-09 | Thomas MacArthur | buy | $1K – $15K |
| 2016-12-08 | Thomas MacArthur | sell | $1K – $15K |